Krilogy Financial LLC Gilead Sciences, Inc. Transaction History

Krilogy Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $225,693 - $294,512	-3,728 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $56,881 - $62,978	798 Added 27.24%	3,728 $288,000
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $81,943 - $95,583	-1,263 Reduced 30.12%	2,930 $208,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $103,651 - $126,362	-1,423 Reduced 25.34%	4,193 $316,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $24,617 - $28,897	-346 Reduced 5.8%	5,616 $402,000
Q3 2017 Nov 15, 2017	SELL	$72.11 - $85.47 $19,181 - $22,735	-266 Reduced 4.27%	5,962 $483,000
Q2 2017 Aug 15, 2017	BUY	N/A	6,228	6,228 $441,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.